University of the Philippines   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Quezon City Philippines (1908)

Organization Overview

First Clinical Trial
2002
NCT00386958
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Department of Neurosciences, University of the Philippines Manila | Philippine General Hospital | Philippine General Hospital, Manila Philippines | Philippine General Hospital (PGH) | Philippine General Hospital, University of the Philippines | Philippines General Hospital | University of the Philippines | University of the Philippines College of Medicine | University of the Philippines Manila | University of the Philippines Manila-National Institutes of Health | University of the Philippines Manila - Philippine General Hospital | University of the Philippines-Philippine General Hospital Section of Dermatology | UP Manila | UP Philippine General Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenoviridae Infections (Phase 4)

Asthma (Phase 4)

Bipolar Disorder (Phase 4)

Blindness (Phase 2)

Burns (Phase 3)

Carcinoma (Phase 2)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 3)

Compartment Syndromes (Phase 4)

Conjunctivitis (Phase 4)

Corneal Ulcer (Phase 2)

Dermatitis (Phase 4)

Diaper Rash (Phase 4)

Emergencies (Phase 4)

Gestational Trophoblastic Disease (Phase 3)

Hydatidiform Mole (Phase 3)

Hypertension (Phase 4)

Infections (Phase 3)

Intra-Abdominal Hypertension (Phase 4)

Keratitis (Phase 2)

Keratoconjunctivitis (Phase 4)

Lung Diseases (Phase 4)

Psoriasis (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Surgical Wound Infection (Phase 3)

Typhoid Fever (Phase 3)

Ulcer (Phase 2)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial APIs: 38